The FDA Warned 30 Telehealth Companies and Big Pharma Smiled
The FDA sent warning letters to 30 telehealth firms over compounded GLP-1 marketing while Novo Nordisk sued Hims -- consumer safety or corporate protectionism?
Life
Stopping Ozempic Raises Cardiovascular Risk by 22 Percent
A major study found that patients who stopped GLP-1 drugs for two years faced a 22 percent increase in heart attack, stroke, and death risk.
The Wegovy Pill Has 400,000 Americans and Weight Loss Will Never Be the Same
Oral Wegovy reached 400,000 American users within ten weeks of FDA approval, making it the fastest-adopted obesity drug in history.
GLP-1 Drugs May Also Reduce Substance Use Disorders
A study of 600,000 veterans found GLP-1 drugs reduced alcohol use disorder risk by 18 percent, opioid risk by 25 percent, and cocaine risk by 20 percent.
Ozempic Is Changing What Restaurants Serve and Nobody Asked the Chefs
Olive Garden, Cheesecake Factory, and Chipotle are all cutting portion sizes and adding high-protein menus to serve customers on GLP-1 drugs.
The Catholic Convert Surge Continued Through Lent and Nobody Can Explain Why
US Catholic dioceses report record numbers of adult converts for Easter 2026, with Detroit at a 21-year high and Los Angeles expecting 8,598 new members.
Lancet Study: Global Heating Could Drive 500,000 Extra Deaths Per Year by 2050 Through Reduced Physical Activity
A Lancet Global Health modeling study projects rising temperatures will push millions into physical inactivity, causing 500,000+ premature deaths annually by 2050.
GLP-1 Drugs Are Reshaping Society Far Beyond Medicine: Dating, Insurance, Fashion, Food
GLP-1 weight-loss drugs are now transforming dating culture, insurance markets, fashion, and the food industry as adoption reaches 1 in 8 US adults.
LaGuardia Investigation: No New NTSB Directive This Edition
The NTSB investigation into the March 22 LaGuardia runway collision continues with no new directives or findings released this week.